Search
for
Sort by
Research 751–780 of 1000+
- Severe steroid-dependent idiopathic angioedema with response to rituximab
- Hair loss
- Appearance of alopecia areata during treatment with tildrakizumab for severe palmoplantar psoriasis
- Hair loss in infancy and childhood
- Deucravacitinib in dermatology: current indication and existing off-label data
- Cutaneous lupus erythematosus. Diagnostic and therapeutic recommendations of the Polish Dermatological Society
- The Yin and Yang of Integrin Function in Re-Epithelialization During Wound Healing
- Evaluation of dermatologic adverse events associated with aromatase inhibitors: insights from the FAERS database
- Expanding the Scope of PROTACs: Opportunities and Challenges in Topical Delivery
- The Biology of Hair Follicles
- Dynamic Trichoscopy
- From neural crest cells to melanocytes: cellular plasticity during development and beyond
- A study on dermatoses of pregnancy
- Human epithelial hair follicle stem cells and their progeny: Current state of knowledge, the widening gap in translational research and future challenges
- A review on traditional uses, phytochemistry and pharmacology of Eclipta prostrata (L.) L.
- Historical and Current Adenosine Receptor Agonists in Preclinical and Clinical Development
- Clinical Case Notes. Castleman's disease of the lacrimal gland
- Management of Toxicities of Targeted Therapies
- Schimmelpenning syndrome with dydimosis aplasticosebacea in a one-month-old girl
- Aldesleukin
- The diagnosis and management of alopecia
- Extraskeletal actions of vitamin D
- Alopecia Areata after COVID-19 Vaccines
- Proposing a Simpler Classification of Telogen Effluvium
- A Case of Frontal Fibrosing Alopecia in a Patient with Primary Biliary Cirrhosis and Polymyalgia Rheumatica
- Hair Follicle Melanogenesis Reflected in Hair Pigmentation as a Developmental Factor in Alopecia Areata
- Alopecia Areata Barbae in a Nutshell
- Telogen Effluvium: Is There a Need for a New Classification A Reply
- Nail Involvement in Refractory Pediatric Alopecia Areata: A Duration-Dependent Finding
- Upadacitinib for Alopecia: Current Evidence and Clinical Insights